If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Half Year 2023 Trading Update

18 May 2023 07:00

RNS Number : 7856Z
IDOX PLC
18 May 2023
 

18 May 2023

Idox plc

('Idox' or the 'Group' or the 'Company')

Half Year 2023 Trading Update

Good first half performance, positive momentum and continued cash generation

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial half year ended 30 April 2023 ('FY23 H1').

 

 

Group trading performance

 

We are pleased to report that the Group has delivered a good performance during the first six months of the year with year-on-year adjusted EBITDA growth of c.10%. Operating under a new tripartite divisional structure of Land, Property & Public Protection, Communities and Assets, the Group continues to make encouraging progress in its chosen markets.

 

The Group delivered a significant increase in order intake during the period of c.£52m (up 23% from FY22 H1) providing good levels of recurring revenue visibility for the remainder of FY23 and into FY24.

 

The Board expects to report a c.10% increase in adjusted EBITDA to c.£12m, in line with management expectations. Revenue was up c.8% to c.£36m, within which recurring revenue was up c.7% over the period to c.£21m.

 

The Group continued to generate strong cash flow during the period and ended the half with a net cash position of c.£1m compared to a net debt position of £6.7m as at 31 October 2022 (net debt of £3.8m as at 30 April 2022).

 

 

David Meaden, Chief Executive of Idox commented:

 

"The Group has delivered a good performance for the period in a challenging macro-economic environment.

 

We have continued to secure both new clients and new contracts with key customers, which has resulted in significantly higher order intake, providing good visibility into the future. As anticipated, the Group has delivered double digit profit growth in the period.

 

Our focus on cash generation has ensured we ended the period with net cash, compared to net debt at the year end. Combined with our available debt facilities, this enables us to continue to pursue attractive acquisition targets that we believe will generate value for all shareholders.

 

We are pleased with our progress and momentum and are on track to deliver on our plans for the remainder of 2023."

 

 

Notice of half year results

 

The Group expects to report its FY23 H1 results on Thursday 8 June 2023. Management will host a results webinar on the day. Please contact MHP to register your interest.

 

 

1 Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

2 Net cash / (debt) is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Anoop Kang, Chief Financial Officer

 

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Michael Burke

James Smith

 

MHP

+ 44 (0) 20 3128 8170

Reg Hoare 

Ollie Hoare

Matthew Taylor

idox@mhpgroup.com

 

 

About Idox plc

For more information see www.idoxgroup.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGMKVNZGFZM
Date   Source Headline
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company
7th Oct 20222:42 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSAcquisition
26th Sep 20227:00 amRNSExercise of Share Options & Total Voting Rights
1st Aug 20227:00 amRNSTotal Voting Rights
15th Jul 20227:00 amRNSIdox awarded new contract for Idox Cloud
28th Jun 20227:00 amRNSIssue of Equity
15th Jun 20227:00 amRNSHalf-year Report
19th May 20227:00 amRNSFY22 H1 trading update
19th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSGrant of Options
28th Mar 20227:13 amRNSExercise of Share Options & Total Voting Rights
23rd Mar 20229:51 amRNSExercise of Share Options & Total Voting Rights
16th Mar 202211:22 amRNSResult of AGM & Board Change
16th Mar 20227:00 amRNSAGM Trading Update
21st Feb 20227:01 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.